STOCK TITAN

Neogen (NASDAQ: NEOG) CFO and COO to resign with transition deal

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Neogen Corporation reported that its Chief Financial Officer and Chief Operating Officer, David Naemura, has informed the company of his intention to resign to pursue other opportunities. The company stated that his decision is not related to any disagreement over operations, financial statements, accounting policies, or internal controls. He will continue in his current roles until a departure date expected between the filing of Neogen’s October Form 10-Q and the end of the calendar year, helping ensure continuity.

The board’s Compensation and Talent Management Committee determined it is in the company’s and shareholders’ best interests for Naemura to assist with onboarding a new Chief Financial Officer. Under a transition agreement, if he remains employed through December 31, 2025, he will be eligible, in addition to his base pay, to receive 50% of his annual target cash bonus under Neogen’s annual incentive plan. Neogen also issued a press release announcing his resignation.

Positive

  • None.

Negative

  • Neogen’s combined Chief Financial Officer and Chief Operating Officer, David Naemura, intends to resign, creating a notable senior leadership transition.

Insights

Neogen’s CFO/COO plans to resign, with a structured transition in place.

The company disclosed that David Naemura, who serves as both Chief Financial Officer and Chief Operating Officer, has communicated his intention to resign to pursue other opportunities. The filing explicitly notes that his decision is not due to any disagreement over operations, financial statements, accounting policies, or internal controls, which helps reduce concern about immediate governance or reporting issues.

Naemura is expected to remain in his roles until sometime between the company’s Form 10-Q filing in October and the end of the calendar year, providing an overlap period. The board’s Compensation and Talent Management Committee has approved a transition agreement that offers eligibility for 50% of his annual target cash bonus if he stays through December 31, 2025, on top of his base compensation. This structure is designed to support an orderly handover and onboarding of a new CFO, though the departure of a combined CFO/COO is still a notable leadership change.

0000711377false00007113772025-09-122025-09-12

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 12, 2025

 

 

Neogen Corporation

(Exact name of Registrant as Specified in Its Charter)

 

 

Michigan

0-17988

38-2367843

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

620 Lesher Place

 

Lansing, Michigan

 

48912

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (517) 372-9200

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, $0.16 par value per share

 

NEOG

 

Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 15, 2025, Neogen Corporation (the “Company”) announced that David Naemura, the Company’s Chief Financial Officer and Chief Operating Officer, communicated his intention to resign and pursue other opportunities to the Company on September 12, 2025. This decision is not due to any disagreement regarding the Company’s operations, financial statements, accounting policies or internal controls.

Mr. Naemura will continue to serve in his existing roles until his departure, which is expected to occur between the filing of the Company’s Form 10-Q in October and the end of the calendar year.

The Compensation and Talent Management Committee of the Board has determined that it is in the best interests of the Company and its shareholders for Mr. Naemura to assist with onboarding of a new Chief Financial Officer. The Company has entered into a transition agreement with Mr. Naemura that provides that, if he remains employed at the Company through December 31, 2025, in addition to his current base compensation, Mr. Naemura is eligible to receive 50% of his annual target cash bonus under the Company’s annual incentive compensation plan.

Item 8.01 Other Events.

On September 15, 2025, Neogen issued a press release announcing the resignation of the current Chief Financial Officer and Chief Operating Officer. A copy of this press release is furnished as Exhibit 99.2.

Item 9.01 Financial Statements and Exhibits.

d) Exhibits

99.1

99.2

Naemura Transition Letter Agreement

September 15, 2025, Press Release

104

Cover Page Interactive Data File (embedded within the Inline XBRL document).

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

NEOGEN CORPORATION

 

 

 

 

Date:

September 15, 2025

By:

/s/ Amy M. Rocklin

 

 

 

Name: Amy M. Rocklin
Title: Chief Legal & Compliance Officer, Corporate Secretary
 

 

 


FAQ

What leadership change did Neogen (NEOG) disclose in this 8-K?

Neogen reported that David Naemura, its Chief Financial Officer and Chief Operating Officer, has communicated his intention to resign to pursue other opportunities.

Did Neogen (NEOG) indicate any disagreement behind the CFO/COO resignation?

Neogen stated that Mr. Naemura’s decision to resign is not due to any disagreement regarding the company’s operations, financial statements, accounting policies, or internal controls.

How long will Neogen’s current CFO and COO remain with the company?

Mr. Naemura will continue in his current roles until his departure, which Neogen expects to occur between the filing of its Form 10-Q in October and the end of the calendar year.

What transition incentives did Neogen (NEOG) offer its departing CFO/COO?

Under a transition agreement, if Mr. Naemura remains employed through December 31, 2025, he is eligible, in addition to base pay, to receive 50% of his annual target cash bonus under Neogen’s annual incentive plan.

How will Neogen manage the handover to a new Chief Financial Officer?

Neogen’s Compensation and Talent Management Committee determined it is in the company’s and shareholders’ best interests for Mr. Naemura to assist with onboarding a new Chief Financial Officer during the transition period.

Did Neogen issue a press release about the CFO/COO resignation?

Yes. Neogen issued a press release on September 15, 2025 announcing the resignation of its current Chief Financial Officer and Chief Operating Officer, which is furnished as Exhibit 99.2.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

2.39B
215.48M
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING